Japan’s PMDA completes GMP inspection at Lupin’s Goa facility

30 Sep 2019 Evaluate

Pharmaceutical and Medical Devices Agency (PMDA), Japan has completed Good Manufacturing Practices (GMP) inspection at Lupin’s Goa facility (Unit - I & II). The inspection was conducted between September 24, 2019 and September 27, 2019. The PMDA inspection closed with no critical or major observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2085.00 29.95 (1.46%)
11-Dec-2025 13:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.05
Dr. Reddys Lab 1274.65
Cipla 1510.00
Zydus Lifesciences 925.30
Lupin 2085.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×